Ugur Sahin – Chief Executive Officer

E812196

Ugur Sahin is a German immunologist, oncologist, and entrepreneur best known as the co-founder and CEO of BioNTech, where he led development of one of the first mRNA-based COVID-19 vaccines.

All labels observed (1)

Label Occurrences
Ugur Sahin – Chief Executive Officer canonical 1

How this entity was disambiguated

Statements (46)

Predicate Object
instanceOf entrepreneur
human
immunologist
academicDegree Doctor of Medicine
awardReceived Axel Springer Award NERFINISHED
Order of Merit of the Federal Republic of Germany NERFINISHED
Paul Ehrlich and Ludwig Darmstaedter Prize NERFINISHED
citizenship Germany
Turkey NERFINISHED
coFounded BioNTech NERFINISHED
collaboratedWith Pfizer NERFINISHED
countryOfBirth Turkey NERFINISHED
dateOfBirth 1965-09-19
educatedAt University of Cologne NERFINISHED
University of Saarland NERFINISHED
employer BioNTech NERFINISHED
ethnicOrigin Turkish
familyName Sahin NERFINISHED
fieldOfWork cancer immunotherapy
immunology
mRNA technology
oncology
gender male
givenName Ugur NERFINISHED
knownFor co-founding BioNTech
developing mRNA-based COVID-19 vaccine
research in cancer immunotherapy
memberOf German National Academy of Sciences Leopoldina NERFINISHED
name Ugur Sahin NERFINISHED
notableAchievement led development of one of the first authorized mRNA COVID-19 vaccines at BioNTech
notableRole Chief Executive Officer of BioNTech NERFINISHED
notableWork development of BNT162b2 COVID-19 vaccine
occupation businessperson
chief executive officer
immunologist
oncologist
university teacher
placeOfBirth Iskenderun NERFINISHED
positionHeld Chief Executive Officer of BioNTech
co-founder of BioNTech
researchInterest T-cell immunology
personalized cancer vaccines
residence Mainz NERFINISHED
spouse Ozlem Tureci NERFINISHED
workLocation Germany
Mainz NERFINISHED

How these facts were elicited

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.

BioNTech positionHeld Ugur Sahin – Chief Executive Officer